Author

Lynnette K. Nieman

National Institute of Diabetes and Digestive and Kidney DiseasesORCID 0000-0003-0534-8025Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Abdel Elkahloun· 1 shared Christina TatsiiD· 1 shared Clarisse QuignoniD· 1 shared Daniela Tortoza Lopez· 1 shared David T. AsuzuiD· 1 shared Debjani MandaliD· 1 shared Dhruval Bhatt· 1 shared Diana Nwokoye· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdel Elkahloun

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 28, 2025

Phosphoproteomic dysregulation drives tumor proliferation in Cushing's disease

David T. Asuzu, Dhruval Bhatt, Dustin Mullaney…·Prashant Chittiboina

This study identifies phosphoproteomic dysregulation as a driver of tumor proliferation in Cushing's disease and demonstrates reversibility using an FDA-approved PP2A agonist.

DOI 10.1101/2025.09.28.679056

humanproteomics

𝕏 PostBluesky